NFKB1 and breast cancer: The first compelling evidence that Wnt/β-catenin negatively regulates NF-κB activity came from the observation that overexpressed β-catenin physically interacted with and inhibited NF-κB function in human colon and breast cancer cells (18) (Table 1).